Juntas Adelante: A Peer-coaching Intervention to Promote Chemoprophylaxis for HIV Prevention among Latina Transgender Women in the Washington DC Metropolitan Area
Project Number5U01PS005218-02
Contact PI/Project LeaderDEL RIO-GONZALEZ, ANA MARIA
Awardee OrganizationGEORGE WASHINGTON UNIVERSITY
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
Transgender women (TW) bear a disproportionate burden of HIV, with one of the single largest HIV-related
disparities found among Latina TW, whose HIV prevalence (26%) is almost four times greater than among their
non-Hispanic White counterparts (7%). Based on findings from our Adelante study, a mixed-methods
longitudinal pilot project assessing awareness and uptake of PrEP and PEP among immigrant LTW in the DC
metropolitan area, this original epidemiological-interventional project seeks to develop and pilot test a peer-
coaching intervention to promote chemoprophylaxis (i.e. PrEP and PEP) for HIV prevention that is culturally
responsive to the characteristics of the LTW community. To achieve this aim we have established a strong
community-academia-government partnership, composed of LTW working for organizations providing services
to the LTW community in the DC metropolitan area, officials from the HIV/AIDS, Hepatitis, STD and TB
Administration (HAHSTA) of the DC Department of Health and researchers from the DC Center for AIDS
Research (DC CFAR). Using a community-based participatory research (CBPR) approach, all members of our
partnership will work collaboratively to develop the intervention, which will include: 1) peer-coaching sessions for
improving HIV-risk assessments, providing information about PrEP/PEP, and supporting PrEP/PEP uptake and
adherence, 2) navigation to existing PrEP/PEP services and 3) other culturally appropriate components deemed
relevant by the CBPR team. We will use a randomized delayed-intervention control trial to examine feasibility,
acceptability and preliminary efficacy, randomizing HIV negative LTW to the intervention (n=25) or a 6-month
waitlist control group (n=25). PrEP/PEP uptake and adherence will be assessed at baseline and 3, 6 and 12-
month follow ups, using self-report, medical records reviews and clinical assays. Intervention feasibility and
acceptability will be assessed using qualitative in-depth individual interviews with participants one month after
intervention completion. Our community-academia-government partnership is ideally suited to carry out the
proposed research with a demonstrated ability to recruit, retain and engage the LTW community in DC in prior HIV
research. For the “Adelante” study we recruited 62 immigrant LTW, with an overall retention rate of 82% for the
longitudinal portion (n=41/50). We have established strong relationships with organizations serving the LTW
community, who will collaborate on this project, ensuring that community needs and priorities drive an effective HIV
response. This proposal complements and extends HAHSTA's HIV prevention efforts towards Ending the HIV
Epidemic (EHE) in DC by 2030. In line with the EHE plan's key strategy to prevent new HIV transmissions by using
proven interventions, this research will support the development of the first evidence-informed HIV prevention
intervention targeting LTW. Results from this study will be used to prepare a NIH R–series award to conduct a more
stringent test of effectiveness of the intervention. This proposal aligns well with the overarching goal of the MARI
program to support innovative implementation science research in a minority community heavily impacted by HIV.
Public Health Relevance Statement
PROJECT NARRATIVE
The proposed original epidemiological pilot project to develop and evaluate a peer-coaching intervention to
promote PrEP and PEP for HIV prevention among Latina transgender women (LTW) is relevant to public
health because, in alignment with the Ending the HIV Epidemic (EHE) plan and CDC's MARI initiative, it seeks
to address the HIV-related health inequities experienced by LTW in Washington DC, a priority city for the EHE
plan. The project advances new horizons in HIV prevention with its specific focus on LTW, its attention to both
PrEP and PEP, and the active involvement of the health department, non-governmental organizations and
LTW community members, elements that will ensure the cultural relevance and potential for sustainability of
the peer-coaching intervention. A significant benefit of the proposed research is that it will lead to the
development of the first Evidence-Informed intervention for HIV prevention targeting LTW, which can be
scalable to reduce the disproportionate burden experienced by LTW in other areas in the US and abroad.
National Center for HIVAIDS, Viral Hepatitis, STD, and TB Prevention
CFDA Code
943
DUNS Number
043990498
UEI
ECR5E2LU5BL6
Project Start Date
01-June-2021
Project End Date
31-May-2024
Budget Start Date
01-June-2022
Budget End Date
31-May-2023
Project Funding Information for 2022
Total Funding
$349,353
Direct Costs
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2022
National Center for HIVAIDS, Viral Hepatitis, STD, and TB Prevention
$349,353
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5U01PS005218-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U01PS005218-02
Patents
No Patents information available for 5U01PS005218-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U01PS005218-02
Clinical Studies
No Clinical Studies information available for 5U01PS005218-02
News and More
Related News Releases
No news release information available for 5U01PS005218-02
History
No Historical information available for 5U01PS005218-02
Similar Projects
No Similar Projects information available for 5U01PS005218-02